New visualisation of the Covid-19 virus_edited.jpg

Project Update


In the Media

Check out the stories below to stay up to date with current events!

20200401-GlennHuntPhoto-0142 (1) (1).jpg

Positive outcome for Hendra antibody trial

A process developed by University of Queensland researchers to produce larger quantities of the Hendra virus therapeutic antibody could be expanded to manufacture treatments for other potentially deadly viruses around the world

20200401-GlennHuntPhoto-0461 (1).jpg

CSL signs agreement with Australian Government for UQ vaccine supply

Global biotech company CSL Limited will supply the Australian Government with 51 million doses of The University of Queensland’s COVID-19 vaccine candidate if it proves successful, under a heads of agreement.

CSL expects the first tranche of doses to be available by mid-2021, with additional doses following in late 2021 and early 2022, if late stage clinical trials are successful.